Berdien Siregar

Statistics

Publications

Citations

266

H-Index

Active since

2011

Affiliations

Johnson & Johnson (Netherlands)(Current)

Johnson & Johnson (United States)

Janssen (United States)

Amsterdam Neuroscience

Janssen (Netherlands)

Berdien Siregar is an author at Johnson & Johnson (Netherlands) specializing in antibody characterization, life sciences, and antibody-antigen recognition.

Publications per year

2011–2019

Publications

Immune responses against domain I of β2-glycoprotein I are driven by conformational changes: Domain I of β2-glycoprotein I harbors a cryptic immunogenic epitope

Bas de Laat, Miranda van Berkel, Rolf T. Urbanus et al. · Arthritis & Rheumatism · 2011 · 104 citations

Life Sciences, Biochemistry, Immunology +17

Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology

Xinyi Li, Wouter Koudstaal, Lauren Fletcher et al. · Acta Neuropathologica · 2019 · 55 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Immunological memory to hyperphosphorylated tau in asymptomatic individuals

Gabriel Pascual, Jehangir S. Wadia, Xueyong Zhu et al. · Acta Neuropathologica · 2017 · 50 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

A common antigenic motif recognized by naturally occurring human VH5–51/VL4–1 anti-tau antibodies with distinct functionalities

Adrian Apetri, Rosa Crespo, Jarek Juraszek et al. · Acta Neuropathologica Communications · 2018 · 24 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau

Jeroen van Ameijde, Rosa Crespo, R W Janson et al. · Acta Neuropathologica Communications · 2018 · 23 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

1–5 of 6